Allmed Medical Products Co., Ltd
SZSE:002950.SZ
9.17 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||
| Net Income
| 110.4 | 404.649 | 431.96 | 1,160.463 | 324.198 | 226.31 | 233.308 | 248.118 | 152.599 | 192.467 |
| Depreciation & Amortization
| 229.866 | 193.199 | 147.211 | 142.221 | 121.37 | 111.113 | 84.451 | 77.326 | 74.423 | 66.116 |
| Deferred Income Tax
| -50.759 | 85.74 | 26.682 | 56.658 | 38.779 | -8.67 | -10.525 | -4.221 | 12.802 | 0 |
| Stock Based Compensation
| 0 | -85.74 | -26.682 | -56.658 | -38.779 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| -16.06 | 192.568 | -152.671 | 224.477 | -200.157 | -370.873 | -116.326 | 134.65 | -113.559 | -20.89 |
| Accounts Receivables
| 157.563 | -18.061 | 75.81 | 64.955 | 85.913 | -236.318 | 10.367 | -9.811 | -64.737 | 0 |
| Inventory
| 71.089 | -37.136 | -143.409 | 18.492 | -159.922 | -277.576 | -128.472 | 91.417 | -96.911 | -9.494 |
| Accounts Payables
| -244.712 | 162.025 | -111.755 | 84.372 | -164.926 | 151.692 | 12.304 | 57.265 | 35.286 | 0 |
| Other Working Capital
| -295.471 | 85.74 | 26.682 | 56.658 | 38.779 | -93.296 | 12.146 | 43.233 | -16.649 | -11.396 |
| Other Non Cash Items
| 628.647 | 359.312 | -51.648 | -90.42 | 27.721 | 36.458 | -4.183 | 12.646 | 104.216 | 55.753 |
| Operating Cash Flow
| 426.301 | 1,149.728 | 374.852 | 1,436.741 | 273.132 | 3.009 | 197.25 | 472.739 | 217.679 | 293.445 |
| Investing Activities: | ||||||||||
| Investments In Property Plant And Equipment
| -286.481 | -398.046 | -290.695 | -243.282 | -232.551 | -287.072 | -405.547 | -160.467 | -99.92 | -94.191 |
| Acquisitions Net
| 0.774 | -99.074 | -90.829 | 329.041 | 52.229 | 0 | 408.442 | 160.604 | 100.662 | 94.23 |
| Purchases Of Investments
| -211.533 | -1,978.993 | -2,983.234 | -3,889.26 | -115.672 | -2.401 | -25.642 | -64.65 | -131.821 | -12.88 |
| Sales Maturities Of Investments
| 350.987 | 1,504.297 | 2,899.82 | 3,301.961 | 77.765 | 2.75 | 35.437 | 26.632 | 143.349 | 38.793 |
| Other Investing Activites
| -72.002 | 1.293 | -8.181 | -243.282 | 0.41 | 8.724 | -405.547 | -160.467 | -99.92 | -94.191 |
| Investing Cash Flow
| -218.254 | -970.523 | -473.118 | -744.822 | -217.819 | -277.998 | -392.857 | -198.348 | -87.65 | -68.24 |
| Financing Activities: | ||||||||||
| Debt Repayment
| -205.936 | -2,972.841 | -3,181.665 | -914.516 | -1,522.937 | -1,329.658 | -1,351.531 | -1,377.681 | -1,575.124 | -1,286.099 |
| Common Stock Issued
| 0 | 0 | 0 | 0 | -9.165 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 9.165 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -37.996 | -132.986 | -557.274 | -253.306 | -63.327 | -35.149 | -185.925 | -295.028 | -98.384 | -70.928 |
| Other Financing Activities
| -82.247 | 2,900.332 | 3,206.075 | 1,539.707 | 1,543.837 | 1,756.991 | 1,650.815 | 1,474.155 | 1,584.597 | 1,173.315 |
| Financing Cash Flow
| -328.809 | -236.409 | -552.75 | 358.693 | -85.944 | 392.185 | 113.359 | -198.554 | -88.912 | -183.711 |
| Other Information: | ||||||||||
| Effect Of Forex Changes On Cash
| 7.552 | -102.642 | 11.935 | 8.701 | 2.176 | -14.034 | 6.856 | 0.166 | -5.588 | -2.836 |
| Net Change In Cash
| -125.168 | -159.847 | -639.081 | 1,059.313 | -28.455 | 103.161 | -75.393 | 76.004 | 35.53 | 38.658 |
| Cash At End Of Period
| 397.037 | 502.912 | 662.759 | 1,301.84 | 242.527 | 270.982 | 167.821 | 243.213 | 167.21 | 131.68 |